129 related articles for article (PubMed ID: 36714935)
21. Unmanipulated haploidentical haematopoietic cell transplantation with radiation-free conditioning in Fanconi anaemia: A retrospective analysis from the Chinese Blood and Marrow Transplantation Registry Group.
Xu L; Lu Y; Hu S; Li C; Tang Y; Wang H; Yan J; Chen J; Liu S; Sun Y; Wu X; Lin F; Lu P; Huang X;
Br J Haematol; 2022 Nov; 199(3):401-410. PubMed ID: 35989315
[TBL] [Abstract][Full Text] [Related]
22. Matched sibling donor haematopoietic stem cell transplantation in Fanconi anaemia: an update of the Cincinnati Children's experience.
Farzin A; Davies SM; Smith FO; Filipovich A; Hansen M; Auerbach AD; Harris RE
Br J Haematol; 2007 Feb; 136(4):633-40. PubMed ID: 17367413
[TBL] [Abstract][Full Text] [Related]
23. Bone marrow transplantation for Fanconi anemia using fludarabine-based conditioning.
Stepensky P; Shapira MY; Balashov D; Trakhtman P; Skorobogatova E; Rheingold L; Brooks R; Revel-Vilk S; Weintraub M; Stein J; Maschan A; Or R; Resnick IB
Biol Blood Marrow Transplant; 2011 Sep; 17(9):1282-8. PubMed ID: 21220033
[TBL] [Abstract][Full Text] [Related]
24. Outcome of Fludarabine-Based Conditioning in High-Risk Aplastic Anemia Patients Undergoing Matched Related Donor Transplantation: A Single-Center Study from Pakistan.
Chaudhry QUN; Iftikhar R; Satti TM; Mahmood SK; Ghafoor T; Shamshad GU; Farhan M; Shahbaz N; Khan MA; Khattak TA; Rehman J; Humayun S; Satti HS; Anwer F; Ahmed P
Biol Blood Marrow Transplant; 2019 Dec; 25(12):2375-2382. PubMed ID: 31394274
[TBL] [Abstract][Full Text] [Related]
25. Treatment of Fanconi anemia patients using fludarabine and low-dose TBI, followed by unrelated donor hematopoietic cell transplantation.
Thakar MS; Kurre P; Storb R; Kletzel M; Frangoul H; Pulsipher MA; Leisenring W; Flowers ME; Sandmaier BM; Woolfrey A; Kiem HP
Bone Marrow Transplant; 2011 Apr; 46(4):539-44. PubMed ID: 20581880
[TBL] [Abstract][Full Text] [Related]
26. A Comparison of the Myeloablative Conditioning Regimen Fludarabine/Busulfan with Cyclophosphamide/Total Body Irradiation, for Allogeneic Stem Cell Transplantation in the Modern Era: A Cohort Analysis.
Gooptu M; Kim HT; Ho VT; Alyea EP; Koreth J; Armand P; Ritz J; Nikiforow S; Glotzbecker BE; Nageshwar P; Soiffer RJ; Antin JH; Cutler CS
Biol Blood Marrow Transplant; 2018 Aug; 24(8):1733-1740. PubMed ID: 29555313
[TBL] [Abstract][Full Text] [Related]
27. Cyclophosphamide-based in vivo T-cell depletion for HLA-haploidentical transplantation in Fanconi anemia.
Thakar MS; Bonfim C; Sandmaier BM; O'Donnell P; Ribeiro L; Gooley T; Deeg HJ; Flowers ME; Pasquini R; Storb R; Woolfrey AE; Kiem HP
Pediatr Hematol Oncol; 2012 Sep; 29(6):568-78. PubMed ID: 22839094
[TBL] [Abstract][Full Text] [Related]
28. Allogeneic hematopoietic stem cell transplantation from an alternative stem cell source in Fanconi anemia patients: analysis of 47 patients from a single institution.
de Medeiros CR; Bitencourt MA; Zanis-Neto J; Maluf EC; Carvalho DS; Bonfim CS; Funke VM; Setubal DC; Farah N; Pasquini R
Braz J Med Biol Res; 2006 Oct; 39(10):1297-304. PubMed ID: 17053839
[TBL] [Abstract][Full Text] [Related]
29. Long-term results of non-fludarabine versus fludarabine-based stem cell transplantation without total body irradiation in Fanconi anemia patients.
Hamidieh AA; Alimoghaddam K; Jahani M; Mousavi SA; Iravani M; Bahar B; Jalili M; Jalali A; Behfar M; Ghavamzadeh A
Hematol Oncol Stem Cell Ther; 2011; 4(3):109-15. PubMed ID: 21982883
[TBL] [Abstract][Full Text] [Related]
30. Outcome of patients with Fanconi anemia developing myelodysplasia and acute leukemia who received allogeneic hematopoietic stem cell transplantation: A retrospective analysis on behalf of EBMT group.
Giardino S; de Latour RP; Aljurf M; Eikema DJ; Bosman P; Bertrand Y; Tbakhi A; Holter W; Bornhäuser M; Rössig C; Burkhardt B; Zecca M; Afanasyev B; Michel G; Ganser A; Alseraihy A; Ayas M; Uckan-Cetinkaya D; Bruno B; Patrick K; Bader P; Itälä-Remes M; Rocha V; Jubert C; Diaz MA; Shaw PJ; Junior LGD; Locatelli F; Kröger N; Faraci M; Pierri F; Lanino E; Miano M; Risitano A; Robin M; Dufour C;
Am J Hematol; 2020 Jul; 95(7):809-816. PubMed ID: 32267023
[TBL] [Abstract][Full Text] [Related]
31. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
32. Unrelated donor bone marrow transplantation for Fanconi anemia.
Davies SM; Khan S; Wagner JE; Arthur DC; Auerbach AD; Ramsay NK; Weisdorf DJ
Bone Marrow Transplant; 1996 Jan; 17(1):43-7. PubMed ID: 8673053
[TBL] [Abstract][Full Text] [Related]
33. Excellent outcome of allogeneic bone marrow transplantation for Fanconi anemia using fludarabine-based reduced-intensity conditioning regimen.
Shimada A; Takahashi Y; Muramatsu H; Hama A; Ismael O; Narita A; Sakaguchi H; Doisaki S; Nishio N; Tanaka M; Yoshida N; Matsumoto K; Kato K; Watanabe N; Kojima S
Int J Hematol; 2012 Jun; 95(6):675-9. PubMed ID: 22527854
[TBL] [Abstract][Full Text] [Related]
34. Feasibility of second hematopoietic stem cell transplantation using reduced-intensity conditioning with fludarabine and melphalan after a failed autologous hematopoietic stem cell transplantation.
Hong JY; Choi MK; Kim DH; Kim SJ; Kim K; Kim WS; Chung CW; Kim HO; Min YH; Jang JH
Transplant Proc; 2010 Nov; 42(9):3723-8. PubMed ID: 21094846
[TBL] [Abstract][Full Text] [Related]
35. Head and neck squamous cell carcinoma in 13 patients with Fanconi anemia after hematopoietic stem cell transplantation.
Masserot C; Peffault de Latour R; Rocha V; Leblanc T; Rigolet A; Pascal F; Janin A; Soulier J; Gluckman E; Socié G
Cancer; 2008 Dec; 113(12):3315-22. PubMed ID: 18831513
[TBL] [Abstract][Full Text] [Related]
36. Late effects in patients with Fanconi anemia following allogeneic hematopoietic stem cell transplantation from alternative donors.
Anur P; Friedman DN; Sklar C; Oeffinger K; Castiel M; Kearney J; Singh B; Prockop SE; Kernan NA; Scaradavou A; Kobos R; Curran K; Ruggiero J; Zakak N; O'Reilly RJ; Boulad F
Bone Marrow Transplant; 2016 Jul; 51(7):938-44. PubMed ID: 26999465
[TBL] [Abstract][Full Text] [Related]
37. Hematopoietic stem cell transplantation using single UM171-expanded cord blood: a single-arm, phase 1-2 safety and feasibility study.
Cohen S; Roy J; Lachance S; Delisle JS; Marinier A; Busque L; Roy DC; Barabé F; Ahmad I; Bambace N; Bernard L; Kiss T; Bouchard P; Caudrelier P; Landais S; Larochelle F; Chagraoui J; Lehnertz B; Corneau S; Tomellini E; van Kampen JJA; Cornelissen JJ; Dumont-Lagacé M; Tanguay M; Li Q; Lemieux S; Zandstra PW; Sauvageau G
Lancet Haematol; 2020 Feb; 7(2):e134-e145. PubMed ID: 31704264
[TBL] [Abstract][Full Text] [Related]
38. Non-genotoxic Restoration of the Hematolymphoid System in Fanconi Anemia.
Chan YY; Ho PY; Swartzrock L; Rayburn M; Nofal R; Thongthip S; Weinberg KI; Czechowicz A
Transplant Cell Ther; 2023 Mar; 29(3):164.e1-164.e9. PubMed ID: 35995393
[TBL] [Abstract][Full Text] [Related]
39. Successful Outcome in Patients with Fanconi Anemia Undergoing T Cell-Replete Mismatched Related Donor Hematopoietic Cell Transplantation Using Reduced-Dose Cyclophosphamide Post-Transplantation.
Ayas M; Siddiqui K; Al-Jefri A; Al-Ahmari A; Ghemlas I; Al-Saedi H; Alanazi A; Jafri R; Ayas MF; Al-Seraihi A
Biol Blood Marrow Transplant; 2019 Nov; 25(11):2217-2221. PubMed ID: 31306778
[TBL] [Abstract][Full Text] [Related]
40. HLA-haploidentical T cell-depleted allogeneic hematopoietic stem cell transplantation in children with Fanconi anemia.
Zecca M; Strocchio L; Pagliara D; Comoli P; Bertaina A; Giorgiani G; Perotti C; Corbella F; Brescia L; Locatelli F
Biol Blood Marrow Transplant; 2014 Apr; 20(4):571-6. PubMed ID: 24462983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
